abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Other Income/Expenses (Net)
-$9.55M
TTM · Period ending: · USD
HQL Other Income/Expenses (Net)
Latest reported-$9.55Mperiod ending
Latest reported-$9.55Mperiod ending
HQL TTM Other Income/Expenses (Net) ($40.00M → -$9.55M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
HQL other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -9,551,964 | |
| 41,357,818 | |
| 41,354,833 | |
| 121,957,525 | |
| 58,645,925 | |
| 7,738,560 | |
| 7,753,604 | |
| -26,997,927 | |
| -5,867 | |
| -6,948 | |
| -30,077,041 | |
| -67,610,757 | |
| -17,363,200 | |
| -35,328,240 | |
| 38,593,672 | |
| 104,705,790 | |
| 113,608,746 | |
| 62,282,467 | |
| -32,134,604 | |
| 32,732,678 | |
| 29,365,688 | |
| 135,917,697 | |
| 246,791,190 | |
| 153,367,083 | |
| 121,160,245 | |
| 139,247,562 | |
| 99,562,262 | |
| 120,183,515 | |
| 102,694,343 | |
| 53,420,000 | |
| 23,525,000 | |
| -6,370,000 | |
| 19,140,000 | |
| 44,650,000 | |
| 80,020,000 | |
| 115,390,000 | |
| 73,755,000 | |
| 32,120,000 | |
| 29,685,000 | |
| 27,250,000 | |
| 42,415,000 | |
| 57,580,000 | |
| 54,385,000 | |
| 51,190,000 | |
| 22,130,000 | |
| -6,930,000 | |
| -73,955,000 | |
| -140,980,000 | |
| -131,350,000 | |
| -121,720,000 | |
| -66,815,000 | |
| -11,910,000 | |
| 14,045,000 | |
| 40,000,000 |